Evidence map›Paper›PMID 27725577›Full record

ArticleMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine2017

Benefit of 3T Diffusion-weighted Imaging in Comparison to Contrast-enhanced MR Imaging for the Evaluation of Disseminated Lesions in Primary Malignant Brain Tumors.

Yoshihito Kadota, Toshinori Hirai, Hideo Nakamura, Keishi Makino, Shigetoshi Yano, Shinichiro Nishimura, Machiko Tateishi, Minako Azuma, Mika Kitajima, Yasuyuki Yamashita

Open access · diamondAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yoshihito KadotaDepartment of Radiology, Faculty of Medicine, University of Miyazaki.
Toshinori HiraiDepartment of Radiology, Faculty of Medicine, University of Miyazaki.
Hideo NakamuraDepartment of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University.
Keishi MakinoDepartment of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University.
Shigetoshi YanoDepartment of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University.
Shinichiro NishimuraDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
Machiko TateishiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
Minako AzumaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
Mika KitajimaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
Yasuyuki YamashitaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University.
Kumamoto University · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to determine whether 3T diffusion-weighted imaging (DWI) has an additive value relative to contrast-enhanced MR imaging for the detection of disseminated lesions in patients with primary malignant brain tumors.

methodsWe included consecutive 12 patients with nodular disseminated lesions of primary malignant brain tumors that were confirmed by surgery or follow-up MR imaging. All underwent conventional MR imaging, DWI at b = 1000 and 3000 s/mm

resultsCompared with postcontrast studies, radiologists 1 and 2, respectively, assigned more apparent lesion conspicuity in 2 (17%) and 1 (8%) DWI at b = 1000 s/mm

conclusionIn the detection of disseminated lesions in patients with primary malignant brain tumors, 3T DWI has an additive value relative to contrast-enhanced MR imaging. DWI at b = 3000 s/mm

Indexed as

AdolescentAdultAgedAged, 80 and overBrain NeoplasmsChildDiffusion Magnetic Resonance ImagingFemaleHumansImage EnhancementMaleMiddle AgedYoung Adult3T MRIdiffusion-weighted imagingdisseminationhigh-b value

Identifiers

PMID27725577
PMCPMC5600028
OpenAlexW2530287414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.